Moderna names new CCO and expands president's role ahead of product launches
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028
June 16, 2026 7:31 AM EDTDr. Stephen Hoge, President of Moderna, to Assume an Expanded Role With Operational Oversight of the Company's Infectious Disease, Intismeran and Rare Disease Franchises
Ester Banque to Join Moderna as Chief Commercial Officer
CAMBRIDGE, MA / ACCESS Newswire / June 16, 2026 / Moderna, Inc. (NASDAQ: MRNA) today announced changes to its operating model to support its short- and long-term business goals.
As Moderna executes its long-range plan to become a diversified, multi-modality biotechnology company, the Company is... More
